123 related articles for article (PubMed ID: 8986114)
1. Rapid detection of factor V Leiden (FVQ506) by non-radioactive single strand conformation polymorphism (SSCP).
Arruda VR; von Zuben PM; Annichino-Bizzachi JM; Costa FF
Sangre (Barc); 1996 Oct; 41(5):379-81. PubMed ID: 8986114
[TBL] [Abstract][Full Text] [Related]
2. Detection of factor V Leiden from a drop of blood by PCR-SSCP.
Corral J; Iniesta JA; González-Conejero R; Vicente V
Thromb Haemost; 1996 Nov; 76(5):735-7. PubMed ID: 8950782
[TBL] [Abstract][Full Text] [Related]
3. Phenotyping and genotyping of coagulation factor V Leiden.
Engel H; Zwang L; van Vliet HH; Michiels JJ; Stibbe J; Lindemans J
Thromb Haemost; 1996 Feb; 75(2):267-9. PubMed ID: 8815574
[TBL] [Abstract][Full Text] [Related]
4. Detection of the factor V Leiden using SSCP.
Margaglione M; D'Andrea G; Cappucci G; Grandone E; Giuliani N; Colaizzo D; Vecchione G; Di Minno G
Thromb Haemost; 1996 Nov; 76(5):814-5. PubMed ID: 8950796
[No Abstract] [Full Text] [Related]
5. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
Guasch JF; Lensen RP; Bertina RM
Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
[TBL] [Abstract][Full Text] [Related]
6. An overview of methods for detection of factor V Leiden and the prothrombin G20210A mutations.
Cooper PC; Rezende SM
Int J Lab Hematol; 2007 Jun; 29(3):153-62. PubMed ID: 17474891
[TBL] [Abstract][Full Text] [Related]
7. [Activated C protein resistance: laboratory study and prevalence of the defect in the Chilean population].
Pereira J; Quiroga T; Goycoolea M; Muñoz B; Hidalgo P; Kaltwasser G; Mezzano D
Rev Med Chil; 1996 Jun; 124(6):663-8. PubMed ID: 9041721
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden and recurrent venous thromboembolism.
Ridker PM
Thromb Haemost; 1996 Nov; 76(5):815-6. PubMed ID: 8950797
[No Abstract] [Full Text] [Related]
9. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR.
Mitterer M; Lanthaler AJ; Mair W; Giacomuzzi K; Coser P
Haematologica; 1999 Mar; 84(3):204-7. PubMed ID: 10189382
[TBL] [Abstract][Full Text] [Related]
11. Factor V Leiden is not common in children with portal vein thrombosis.
Seixas CA; Hessel G; Ribeiro CC; Arruda VR; Annichino-Bizzacchi JM
Thromb Haemost; 1997 Feb; 77(2):258-61. PubMed ID: 9157577
[TBL] [Abstract][Full Text] [Related]
12. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece.
Ioannou HV; Mitsis M; Eleftheriou A; Matsagas M; Nousias V; Rigopoulos C; Vartholomatos G; Kappas AM
Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729
[TBL] [Abstract][Full Text] [Related]
14. Simple and reliable factor V genotyping by PNA-mediated PCR clamping.
Behn M; Schuermann M
Thromb Haemost; 1998 Apr; 79(4):773-7. PubMed ID: 9569191
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
[TBL] [Abstract][Full Text] [Related]
16. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
Dahlbäck B
Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
[No Abstract] [Full Text] [Related]
17. Detection of known thalassemia point mutations by snapback single-strand conformation polymorphism: the feasibility analysis.
Li W; Gao F; Tang W; Zhang X; Zhang H
Clin Biochem; 2006 Aug; 39(8):833-42. PubMed ID: 16820146
[TBL] [Abstract][Full Text] [Related]
18. The factor V gene A4070G mutation and the risk of venous thrombosis.
Alhenc-Gelas M; Nicaud V; Gandrille S; van Dreden P; Amiral J; Aubry ML; Fiessinger JN; Emmerich J; Aiach M
Thromb Haemost; 1999 Feb; 81(2):193-7. PubMed ID: 10063990
[TBL] [Abstract][Full Text] [Related]
19. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
Graf LL; Welsh CH; Qamar Z; Marlar RA
Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].
Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E
Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
